See All Slides - tctmd.com

Slides

Presentation TCT 2013

Emerging Funding Models and Partnerships: Fueling the Innovation Engine

Presenter: Casey McGlynn

October 28, 2013

Presentation TCT 2013

Case Presentation: A Patient with Cardiogenic Shock in STEMI

Presenter: Alexander Osiev

October 28, 2013

Presentation TCT 2013

Temporary Right Heart Support

Presenter: Jose Henriques

October 28, 2013

Presentation TCT 2013

Potential for Ventricular Reshaping: Insights from STICH and Other Surgical Studies

Presenter: Robert Michler

October 28, 2013

Presentation TCT 2013

Who Should Be Operated on for Functional MR? Guidelines and Practice (Heart Failure Specialist Perspectives)

Presenter: JoAnn Lindenfeld

October 28, 2013

Presentation TCT 2013

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Presenter: Richard Heuser

October 28, 2013

Presentation TCT 2013

Primary PCI in Russia: Insights from the National Federation Database

Presenter: Bagrat Alekyan

October 28, 2013

Presentation TCT 2013

The Hybrid Approach I: The Algorithm and the Registry

Presenter: David Daniels

October 28, 2013

Presentation TCT 2013

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

Presenter: Andrew Farb

October 28, 2013

Presentation TCT 2013

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Presenter: Finn Gustafsson

October 28, 2013

Advertisement

Slides

Emerging Funding Models and Partnerships: Fueling the Innovation Engine

Case Presentation: A Patient with Cardiogenic Shock in STEMI

Temporary Right Heart Support

Potential for Ventricular Reshaping: Insights from STICH and Other Surgical Studies

Who Should Be Operated on for Functional MR? Guidelines and Practice (Heart Failure Specialist Perspectives)

Trans-ureteral Renal Sympathetic Denervation (Verve Medical)

Primary PCI in Russia: Insights from the National Federation Database

The Hybrid Approach I: The Algorithm and the Registry

New FDA Innovation Pathways: Returning Early Stage Device Development to the United States

TCT-136. Results of a Novel Interatrial Shunt Therapy for Heart Failure and Preserved or Mildly Reduced Ejection Fraction

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content